Profile
Full Name
Plus Therapeutics, Inc.Ticker Symbol
PSTVExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
July 11, 2001Indexes
Not includedWebsite
http://plustherapeutics.comEmployees
21Key Details
Price
$0.63(-3.09%)
Market cap
$10.71M(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
-
Annual EPS
-$2.34(+44.81% YoY)
PE ratio
-
Next earnings date
N/ANext ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Plus Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Mar 28, 25 HC Wainwright & Co.
BuyMar 28, 25 D. Boral Capital
BuyMar 21, 25 D. Boral Capital
BuyMar 17, 25 D. Boral Capital
BuyDec 9, 24 Ascendiant Capital
BuyNov 26, 24 HC Wainwright & Co.
BuyNov 15, 24 HC Wainwright & Co.
BuyAug 16, 24 HC Wainwright & Co.
BuyAug 15, 23 HC Wainwright & Co.
BuyAug 14, 23 HC Wainwright & Co.
BuyInstitutional Ownership
- What is the ticker symbol for Plus Therapeutics?
- Does Plus Therapeutics pay dividends?
- What sector is Plus Therapeutics in?
- What industry is Plus Therapeutics in?
- What country is Plus Therapeutics based in?
- When did Plus Therapeutics go public?
- Is Plus Therapeutics in the S&P 500?
- Is Plus Therapeutics in the NASDAQ 100?
- Is Plus Therapeutics in the Dow Jones?
- When was Plus Therapeutics's last earnings report?
- When does Plus Therapeutics report earnings?
- Should I buy Plus Therapeutics stock now?
What is the ticker symbol for Plus Therapeutics?
The ticker symbol for Plus Therapeutics is NASDAQ:PSTV
Does Plus Therapeutics pay dividends?
No, Plus Therapeutics does not pay dividends
What sector is Plus Therapeutics in?
Plus Therapeutics is in the Healthcare sector
What industry is Plus Therapeutics in?
Plus Therapeutics is in the Biotechnology industry
What country is Plus Therapeutics based in?
Plus Therapeutics is headquartered in United States
When did Plus Therapeutics go public?
Plus Therapeutics's initial public offering (IPO) was on July 11, 2001
Is Plus Therapeutics in the S&P 500?
No, Plus Therapeutics is not included in the S&P 500 index
Is Plus Therapeutics in the NASDAQ 100?
No, Plus Therapeutics is not included in the NASDAQ 100 index
Is Plus Therapeutics in the Dow Jones?
No, Plus Therapeutics is not included in the Dow Jones index
When was Plus Therapeutics's last earnings report?
Plus Therapeutics's most recent earnings report was on Jul 22, 2021
When does Plus Therapeutics report earnings?
The date for Plus Therapeutics's next earnings report has not been announced yet
Should I buy Plus Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions